Tag Archivio per: CHMP
https://www.pharmadoc.it/wp-content/uploads/2020/09/Gennazzani-Armando-2.png
990
1428
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2020-09-12 10:06:102020-09-12 10:07:07Armando Genazzani al CHMP di EMA
https://www.pharmadoc.it/wp-content/uploads/2019/10/Patient-safety-1.jpg
1183
1743
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2019-10-15 12:27:152019-10-29 16:58:18Il rapporto rischio/beneficio – probatio diabolica per le aziende farmaceutiche? Il caso della sospensione dell’AIC per i prodotti a base di gadolinio.